Fig. 6.
Mesenchymal transition protects tumor cells from macrophage induced cytotoxicity. (A) MTT viability assays of PANC-1 shCtrl, shZEB1 #1 and shZEB1 #2 cells treated with RPMI-1640 (green bars) or M0-CM (blue bars). PAR1 was inhibited by Vorapaxar (500 nM), MMP9 was inhibited by GM6001 (5 μM), and DMSO served as a mock control. Decreased viability was calculated relative to the viability of control-treated cells. Shown is the mean ± SEM (n = 6); One-way ANOVA. (B) Schematic representation showing that macrophages secrete MMP9 that activates PAR1 on pancreatic cancer cells, thereby inducing mesenchymal transition and subsequent resistance to macrophage-induced cytotoxicity